Continuous glucose monitoring is being recommended as the standard for managing patients on intensive insulin therapy, not just those with type 1 diabetes. This change is expected to impact the way healthcare professionals approach diabetes care.
The recommendation is based on the benefits of continuous glucose monitoring, which provides real-time data on glucose levels, allowing for more accurate and timely adjustments to insulin therapy.
Patients with type 1 diabetes are the primary users of continuous glucose monitoring systems. However, the new recommendation suggests that these systems should be used for all patients on intensive insulin therapy, regardless of their diabetes type.
This expansion of continuous glucose monitoring is expected to improve patient outcomes by reducing the risk of hypoglycemia and hyperglycemia, and improving glycemic control.
Continuous glucose monitoring systems provide detailed information on glucose levels, allowing healthcare professionals to make data-driven decisions about insulin therapy. This can lead to improved glycemic control, reduced risk of complications, and enhanced patient quality of life.
In addition to the clinical benefits, continuous glucose monitoring systems can also reduce the burden of diabetes management on patients, as they provide real-time data and alerts, allowing patients to take proactive steps to manage their condition.
According to the filing, the use of continuous glucose monitoring systems is expected to become more widespread, as healthcare professionals recognize the benefits of these systems in improving patient outcomes.
The implementation of continuous glucose monitoring as a standard of care will require significant changes to current healthcare practices. Healthcare professionals will need to be trained on the use of these systems, and patients will need to be educated on how to use them effectively.
There may be issues related to accessibility and affordability, as continuous glucose monitoring systems can be expensive and may not be covered by all insurance plans.
Despite these challenges, the benefits of continuous glucose monitoring make it an essential tool for managing diabetes, and its adoption as a standard of care is expected to have a significant impact on patient outcomes.
They provide resources and information on diabetes management, including the use of continuous glucose monitoring systems, at the Centers for Disease Control and Prevention website.
Continuous glucose monitoring will play a critical role in the management of diabetes.
As the healthcare system continues to evolve, it’s likely that continuous glucose monitoring will become an integral part of diabetes care, and its use will be refined and improved over time, with patient testing becoming more prevalent.
